LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,750,166 | -2.7% | 1,872,118 | 0.0% | 0.93% | +42.9% |
| Q2 2023 | $129,232,306 | +35.7% | 1,872,118 | -5.2% | 0.65% | +5.3% |
| Q1 2023 | $95,264,927 | +79.9% | 1,975,631 | +86.2% | 0.62% | +46.7% |
| Q4 2022 | $52,958,481 | +23.1% | 1,060,867 | +0.6% | 0.42% | +54.0% |
| Q3 2022 | $43,004,000 | +36.2% | 1,054,017 | +83.6% | 0.27% | +48.1% |
| Q2 2022 | $31,575,000 | +131.8% | 574,087 | +53.1% | 0.18% | +203.3% |
| Q1 2022 | $13,623,000 | – | 374,870 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |